Carer burden in apathy and impulse control disorders in Parkinson's disease
β Scribed by Iracema Leroi; Vijay Harbishettar; Michelle Andrews; Kathryn McDonald; E. Jane Byrne; Alistair Burns
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 142 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.2704
No coin nor oath required. For personal study only.
β¦ Synopsis
Background
The neuropsychiatric complications of Parkinson's disease (PD), which include behaviour disturbances such as apathy and the impulse control disorders (ICDs), may have a significant effect on patients with PD and their carers. The contribution of these behaviour disorders to carer burden is less understood. Therefore, the aim of this study was to explore the relationship that apathy and ICDs have with carer burden.
Methods
Nonβdemented (nβ=β71) PDβcarer dyads (spouse or adult child) participated in the study. The PD participants were divided into three behavioural groups: ICD (nβ=β21), apathy (nβ=β22) and controls (nβ=β28). The three groups were compared for level of burden in their carers by using the Zarit Burden Interview. The PD participants were rated for levels of apathy, impulsivity and motor and psychiatric symptoms. Using a multivariate analysis, we sought the PDβrelated predictors of carer burden.
Results
Significantly, greater burden was seen in carers of PD participants with ICDs (pβ=β0.002) or apathy (pβ=β0.004), compared with carers of PD participants without such behavioural disturbances. Linear regression models revealed that attentional ability accounted for burden in carers of the group with apathy, whereas dopaminergic load and depression accounted for burden in carers of the group with impulsivity.
Conclusion
PDβrelated behaviour disturbances, such as apathy and ICDs, as well as psychiatric complications, have significant negative implications for burden of care. Copyright Β© 2011 John Wiley & Sons, Ltd.
π SIMILAR VOLUMES
## Abstract A range of behaviors presumed to be related to dopaminergic medications have been recently recognized in Parkinson's disease (PD). We evaluated 50 consecutive cognitively intact PD patients on stable dopamine agonist and levodopa therapy and 100 healthy controls for compulsive sexual be
## Abstract Recent studies have linked dopamine agonist (DA) usage with the development of impulse control disorders (ICDs) in Parkinson's disease (PD). Little is known about optimal management strategies or the longβterm outcomes of affected patients. To report on the clinical interventions and lo
## Abstract A range of impulse control disorders (ICDs) are reported to occur in Parkinson's disease (PD). However, alterations in brain activity at rest and during risk taking occurring with ICDs in PD are not well understood. We used both arterial spin labeling perfusion functional magnetic reson